NY-UPTIME-INSTITUTE
20.9.2022 12:03:37 CEST | Business Wire | Press release
Uptime Institute today announced the release of its 12th Annual Global Data Center Survey. The findings show an industry that is growing, dynamic and increasingly resilient, but still working to address increasing pressure for sustainability progress and reporting, continuing staffing shortages, supply chain delays, costly outages and other complex challenges.
“The global digital infrastructure sector continues to enjoy strong growth and expansion, despite the many obstacles operators are facing today,” said Andy Lawrence, executive director of research, Uptime Institute Intelligence. “We’ve seen the industry invest in increased resiliency and reliability, but there’s still work to be done when it comes to improving efficiency, environmental sustainability, outage prevention, staffing pipelines and more.”
Uptime’s annual Global Data Center Survey is the largest and most comprehensive in the digital infrastructure industry. It provides detailed insights into the digital critical infrastructure landscape and a sense of its future trajectory. Key findings from the 2022 report include:
- Many data center operators are unprepared for mounting sustainability requirements and regulations – Most respondents say they report on overall data center power use and PUE, but many still are not tracking critical environmental metrics. Although 63% of operators believe authorities in their region will require them to publicly report environmental data in the next five years, just 37% collect and report carbon emissions data (a slight increase over 33% in 2021) and only 39% currently report their water use (a 12% drop compared to 2021). New laws, standards, and requirements will force operators to address these gaps and establish more stringent sustainability tracking and reporting practices in the coming years.
- PUE progress is in stasis for now and future efficiency gains must focus on IT power – The average annual power usage effectiveness (PUE) reported in 2022 was 1.55. This represents a slight improvement over the 2021 average of 1.57, which is consistent with the trend of marginal PUE gains Uptime has observed annually since 2014. Going forward, achieving substantial data center efficiency improvements will require a new focus on IT efficiency, along with metrics to track and report progress.
- More operators are investing to bolster data center resiliency – Data center owners and operators are making significant investments in the resiliency of their physical infrastructure, with about 40% of respondents reporting increased redundancy levels at their primary data centers in the past three to five years. Power and cooling systems have received similar attention, with a third of operators upgrading either or both.
- Outages are becoming more expensive and are still far too frequent – The share of all outages costing operators over $1 million has reached 25%, a significant increase from 15% in 2021. In 2022, 60% of operators reported experiencing an outage (regardless of severity) in the past three years — down from 69% in 2021 and 78% in 2020. Although the data indicates a trend toward improved outage rates, the frequency of outages is still much too high and with more than two-thirds now costing operators upwards of $100,000, the consequences are getting worse.
- Operators’ confidence in public cloud is on the rise, despite ongoing outage risks – As the perception of improved visibility into cloud operational resiliency grows, organizations are more likely to trust the cloud for mission-critical workloads. In 2022, just 63% of operators are not placing mission-critical workloads into a public cloud, a substantial drop from almost 75% in 2019. That trust might be misplaced, given that more than one-third of respondents report that public cloud availability zone outages (which are relativity common) would cause significant performance issues.
- Data center equipment vendors optimistic despite demand pressures and lingering supply chain problems – Three-quarters of vendors project year-over-year revenue growth in 2022 despite reporting dampened revenues due to persistent COVID-induced supply chain issues. Nearly half of respondents involved with data center construction have suffered significant delays (or other events) in their supply chains, while one-third have experienced moderate issues.
- Problems attracting and retaining qualified staff are worsening – Over half (53%) of data center operators report difficulty finding qualified employees in 2022 — up from 47% in 2021 and 38% in 2018. And 42% of respondents report issues with staff being hired away (in most cases to data center competitors) – a massive increase over just 17% in 2018, which demonstrates the growing challenge of employee retention throughout the sector.
Learn More: Uptime’s 2022 Global Data Center Survey also includes findings on industry attitudes toward nuclear energy, server refresh rates, rack density trends and much more. Download the complete report here, and register for the webinar covering its key trends and takeaways on September 28th at 11:00 a.m. ET.
About the Survey: Uptime conducts its annual Global Data Center Survey online and by email. This year’s study took place in H1 2022, and includes responses from approximately 800 data center owners and operators responsible for managing infrastructure at the world’s largest IT organizations. It also includes insights from 700 data center suppliers, designers, and advisors worldwide.
About Uptime Institute
Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.
Uptime Institute is headquartered in New York, NY, with offices in Seattle, London, Sao Paulo, Dubai, Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220920005231/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release
The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
